The global computed tomography (CT) market is expected to register consistent growth, expanding at a compound annual rate of ...
Engineering multifunctional extracellular vesicles that can selectively and effectively kill lung cancer cells with minimal ...
Novo Nordisk operates in the pharmaceutical sector, with core franchises in diabetes care and obesity care supported by a ...
Overview: The global Biometrics as a Service (BaaS) market in healthcare is projected to grow at a CAGR of approximately ...
The Leesburg, VA-based company is owned by the Viscogliosi Brothers, a family-owned investment firm mostly in the neuromusculoskeletal market. VB Spine was founded last April through the acquisition ...
First publication of clinical efficacy data for PP353, in development for chronic Low Back PainTrial demonstrated that PP353 delivers clinically ...
New partnerships across life sciences, quantum and advanced connectivity. Multi-million pound investment into UK life sciences' gene therapy ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
In 1971, Julian Tudor Hart wrote that “the availability of good medical care tends to vary inversely with the need of the population served”.1 Amid extraordinary progress in precision therapy, a ...
The next phase of digital mental health adoption depends less on innovation and more on how the industry uses real-world evidence, builds reimbursement frameworks, and applies regulatory precedent to ...
Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results